Ranexa Description

Concise Prescribing Info Bahasa Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Description

Each Ranexa 375 mg prolonged-release tablet contains 375 mg of ranolazine.
Each Ranexa 500 mg prolonged-release tablet contains 500 mg of ranolazine.
Each Ranexa 750 mg prolonged-release tablet contains 750 mg of ranolazine.
Excipients/Inactive Ingredients: Excipients for all ranolazine prolonged-release tablet: Carnauba wax, Hypromellose, Magnesium strearate, Methacrylic acid-ethyl acrylate copolymer (1:1), Microcrystalline cellulose, Sodium hydroxide, Titanium dioxide.
Additional excipients for 375 mg tablet: Macrogol, Polysorbate 80, Blue #2/Indigo Carmine Aluminum Lake (E132).
Additional excipients for 500 mg tablet: Macrogol, Polyvinyl alcohol-part hydrolyzed, Iron oxide yellow (E172), Iron oxide red (E172), Talc.
Additional excipients for 750 mg tablet: Glycerol triacetate, Lactose monohydrate, Blue #1/Brilliant Blue FCF Aluminum Lake (E133), Yellow #5/Tartrazine Aluminum Lake (E102).

ranolazine

Manufacturer:

Transfarma Medica Indah